The BMJ newsletters promo codes, discounts and updates



Add to my subscriptions

GLP-1 agonist shortages will not resolve this year, European drugs agency warns

July 1, 2024

The Offer: European Drugs Agency warns that GLP-1 agonist shortages will persist this year, impacting patient care. Stay informed and take action now!

Summary: The European Drugs Agency has issued a warning that GLP-1 agonist shortages are expected to persist throughout the year, posing a significant challenge to patient care across healthcare facilities. The unavailability of these crucial medications can have detrimental effects on individuals managing diabetes and other conditions that require GLP-1 agonists. It is imperative for healthcare providers to stay informed about this situation and take proactive measures to address the impact of these shortages on their patients. Count on the latest updates and expert insights to navigate through these challenging times.